Use of Artificial Intelligence in Pharmaceutical Supply Chains, Sales and Marketing: Case Study

Pages: 43 Published: January 29, 2021 Report Code: GDHCHT244

  • Overview
  • Key Players
  • Contents
  • Listen
    Text to Speech

The pharmaceutical industry has a reputation as being risk averse to embracing new technologies and spent many years in “watch and wait” mode regarding artificial intelligence (AI). Compared to other industries, pharma has been slow to adopt AI, but there has been increased activity over the past few years. This case study provides an overview of how AI is currently being implemented by the pharmaceutical industry in supply chains and in sales and marketing.

Scope

This case study includes:

Examples of pharma companies leading the integration of AI into their operations

Examples of partnerships between Big Pharma and AI start-ups

Examples of other AI initiatives by pharma, including chatbots for patient engagement and enhancing supply chains

Key Highlights

Pharma has been slow to adopt AI, but increased activity has been seen since 2019. Pharma also plans to invest in AI in the near future.

While COVID-19 may have temporarily shifted investment away from AI, it could actually lead to increased AI adoption.

AI will play a key role in the factories of the future.

AI can help marketing become more targeted and personalized, which has shown to be crucial during the COVID-19 pandemic.

Harnessing the benefits of AI requires pharma companies to navigate a series of practical and ethical challenges.

Reasons to Buy

Develop business strategies by understanding how AI is being used in the biopharmaceutical industry today and how the technology is expected to affect the sector in the future.

Stay up to date on the key players in the AI space in drug development and clinical trials.

See what activities biopharmaceutical companies are undertaking in the space.

Identify opportunities for partnerships with AI vendors.

Key Players

GSK, Novartis, Sanofi, Boehringer Ingelheim, Novo Nordisk, Teva, Insilico

Table of Contents

Summary

Introduction

• Overview of AI

• AI and the Pharmaceutical Industry

• Examples of Leaders in AI Across the Pharmaceutical Industry

• Pharma Plan to Invest in AI in the Next Two Years

• AI Recognized as a Leading Disruptive Technology in Pharma

Artificial Intelligence in Supply Chain

• How AI Can Enhance Pharma Supply Chains

• AI Can Create End-to-End Supply Chain Visibility

• AI Is Enhancing Automation and the Internet of Things

• AI Can Be Used for Demand Forecasting and Inventory Management

• Teva Applying Digital Twins to Improve Production

• GSK Launches AI-Powered Smart Manufacturing Facility

Artificial Intelligence in Sales and Marketing

• AI Has the Potential to Transform Pharma Sales and Marketing

• AI Is Being Used to Segment Customers

• AI Is Being Used to Customize Marketing Campaigns

• Pharma Is Increasingly Using Chatbots to Engage With Customers

• Novartis Launches Chatbot to Support Patients with Chronic Skin Conditions and Arthritis

• Sanofi Genzyme Launches Branded Chatbot to Support Patients with Sleep Disorders

Key Findings

Appendix

• Related Reports

• Abbreviations

• Bibliography

• Our Thematic Research Methodology

• About the Authors

• Contact Us

$495

Can be used by individual purchaser only

$1485

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.